Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 17

Examining Constraints: A Critical Appraisal of Autoimmune Diseases and Facial Aging Study [Letter]

Authors Shuja MH , Hasan M

Received 8 May 2024

Accepted for publication 16 May 2024

Published 18 May 2024 Volume 2024:17 Pages 1145—1146

DOI https://doi.org/10.2147/CCID.S477365

Checked for plagiarism Yes

Editor who approved publication: Prof. Dr. Rungsima Wanitphakdeedecha



Muhammad Hamza Shuja, Minal Hasan

Dow Medical College, Karachi, Sindh, Pakistan

Correspondence: Muhammad Hamza Shuja, Dow Medical College, Dow University of Health Sciences, Baba-e-Urdu Road, Karachi, 74200, Pakistan, Tel +923316079762, Email [email protected]


View the original paper by Dr Zhang and colleagues


Dear editor

We thoroughly reviewed the study titled “Genetically Proxied Autoimmune Diseases and the Risk of Facial Aging” by Zhang et al1 in the esteemed journal “Clinical, Cosmetic and Investigational Dermatology”. The study offers valuable insights into the potential causal relationship between autoimmune diseases and facial skin aging through Mendelian randomization (MR) analyses. However, several limitations diminish the generalizability and reliability of the findings.

Firstly, the study relies heavily on publicly available summary data from genome-wide association studies (GWASs) and questionnaire-based assessments from the UK Biobank raises concerns about data quality and completeness. Without detailed individual-level data, the study lacks the ability to adequately control for various confounding variables that may influence facial aging. These variables include socioeconomic status, environmental factors like pollution and sunlight exposure, lifestyle parameters such as skincare routines, tobacco use, and dietary habits.2 Moreover, focusing solely on 18 autoimmune diseases overlooks potential contributions from other autoimmune conditions, leading to an incomplete understanding of the overall relationship.

Secondly, subjective perception of facial aging through questionnaires introduces bias due to variations among individuals. Employing standardised objective measures, such as validated scales or advanced imaging technologies like 3D facial analysis,3 could mitigate this bias and enhance the reliability of assessments.

While attempts were made to adjust for confounding factors like smoking, alcohol consumption, and body mass index (BMI) in multivariable Mendelian randomization (MVMR) analyses, not all potential confounders were adequately addressed. Specific treatments for autoimmune diseases like psoriasis, eczema, and lupus like topical steroids, were not thoroughly addressed in the study, despite their known association with facial aging through skin thinning.4 Therefore, their exclusion limits the study’s ability to draw accurate conclusions regarding the impact of autoimmune diseases on facial ageing.

Furthermore, Mendelian randomization5 relies on assumptions like the absence of pleiotropy and linkage disequilibrium, which can bias results. Despite conducting sensitivity analyses, the complex nature of autoimmune diseases still poses concerns regarding potential violations of these assumptions. This uncertainty undermines the causal inference regarding the relationship between autoimmune diseases and facial aging.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Zhang Z, Li M, Geng Y, Wang W, Wang W, Shao Y. Genetically proxied autoimmune diseases and the risk of facial aging. Clin Cosmet Invest Dermatol. 2024;17:981–991. doi:10.2147/CCID.S456126

2. Lephart ED, Naftolin F. Factors influencing skin aging and the important role of estrogens and Selective Estrogen Receptor Modulators (SERMs). Clin Cosmet Invest Dermatol. 2022;15:1695–1709. doi:10.2147/CCID.S333663

3. Velemínská J, Jaklová LK, Kočandrlová K, et al. Three-dimensional analysis of modeled facial aging and sexual dimorphism from juvenile to elderly age. Sci Rep. 2022;12(1):21821. doi:10.1038/s41598-022-26376-8

4. Abraham A, Roga G. Topical steroid-damaged skin. Indian J Dermatol. 2014;59(5):456–459. doi:10.4103/0019-5154.139872

5. Boef AG, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol. 2015;44(2):496–511. doi:10.1093/ije/dyv071

Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.